Approval · Notice of Compliance 7736 · 2006
IBUPROFEN CAPLETS: Notice of Compliance 7736
Issued February 3, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7736
- Date
- February 3, 2006
- Company
- Perrigo International, Inc.Allegan, Michigan, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Analgesic, antipyretic
- Canadian reference product
- ADVIL EXTRA STRENGTH CAPLETS (Whitehall-Robins Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN CAPLETS | 02276437 | Cancelled Pre Market |
| IBUPROFEN TABLETS | 02276445 | Cancelled Pre Market |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB